{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T13:02:49Z","timestamp":1793278969108,"version":"4.5.0"},"reference-count":22,"publisher":"Japanese Society of Internal Medicine","issue":"16","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Intern. Med."],"published-print":{"date-parts":[[2022,8,15]]},"DOI":"10.2169\/internalmedicine.8933-21","type":"journal-article","created":{"date-parts":[[2022,8,14]],"date-time":"2022-08-14T22:10:42Z","timestamp":1660515042000},"page":"2489-2495","source":"Crossref","is-referenced-by-count":6,"title":["Hypercalcemia Associated with the Ectopic Expression of 25-hydroxyvitamin D3-1\u03b1-hydroxylase in Diffuse Large B-cell Lymphoma"],"prefix":"10.2169","volume":"61","author":[{"given":"Masashi","family":"Ogawa","sequence":"first","affiliation":[{"name":"Department of Diabetes and Endocrine Disease, Kita-Harima Medical Center, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maho","family":"Morikawa","sequence":"additional","affiliation":[{"name":"Department of Diabetes and Endocrine Disease, Kita-Harima Medical Center, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masaki","family":"Kobatake","sequence":"additional","affiliation":[{"name":"Department of Diabetes and Endocrine Disease, Kita-Harima Medical Center, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taku","family":"Murakami","sequence":"additional","affiliation":[{"name":"Department of Diabetes and Endocrine Disease, Kita-Harima Medical Center, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuki","family":"Yamamoto","sequence":"additional","affiliation":[{"name":"Department of Diagnostic Pathology, Kita-Harima Medical Center, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rikiya","family":"Watanabe","sequence":"additional","affiliation":[{"name":"Department of Internal and Geriatric Medicine, Kita-Harima Medical Center, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katsumi","family":"Yamada","sequence":"additional","affiliation":[{"name":"Department of Internal and Geriatric Medicine, Kita-Harima Medical Center, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katsuhito","family":"Nishiyama","sequence":"additional","affiliation":[{"name":"Department of Diabetes and Endocrine Disease, Kita-Harima Medical Center, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshiro","family":"Yasutomo","sequence":"additional","affiliation":[{"name":"Department of Diabetes and Endocrine Disease, Kita-Harima Medical Center, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenta","family":"Hara","sequence":"additional","affiliation":[{"name":"Department of Diabetes and Endocrine Disease, Kita-Harima Medical Center, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"962","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Burt ME, Brennan MF. Incidence of hypercalcemia and malignant neoplasm. Arch Surg 115: 704-707, 1980.","DOI":"10.1001\/archsurg.1980.01380060012004"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Santarpia L, Koch CA, Sarlis NJ. Hypercalcemia in cancer patients: pathobiology and management. Horm Metab Res 42: 153-164, 2010.","DOI":"10.1055\/s-0029-1241821"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Gastanaga VM, Schwartzberg LS, Jain RK, et al. Prevalence of hypercalcemia among cancer patients in the United States. Cancer Med 5: 2091-2100, 2016.","DOI":"10.1002\/cam4.749"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Andrew F. Hypercalcemia associated with cancer. N Engl J Med 352: 373-379, 2005.","DOI":"10.1056\/NEJMcp042806"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Mirrakhimov AE. Hypercalcemia of malignancy: an update on pathogenesis and management. N Am J Med Sci 7: 483-493, 2015.","DOI":"10.4103\/1947-2714.170600"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Breslau NA, McGuire JL, Zerwekh JE, Frenkel EP, Pak CY. Hypercalcemia associated with Increased serum calcitriol levels in three patients with lymphoma. Ann Intern Med 100: 1-7, 1984.","DOI":"10.7326\/0003-4819-100-1-1"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Davies M, Mawer EB, Hayes ME, Lumb GA. Abnormal vitamin D metabolism in Hodgkin&apos;s lymphoma. Lancet 1: 1186-1188, 1985.","DOI":"10.1016\/S0140-6736(85)92864-8"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Rosenthal N, Insogna KL, Godsall JW, Smaldone L, Waldron JA, Stewart AF. Elevations in circulating 1,25-dihydroxyvitamin D in three patients with lymphoma-associated hypercalcemia. J Clin Endocrinol Metab 60: 29-33, 1985.","DOI":"10.1210\/jcem-60-1-29"},{"key":"9","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1182\/blood.V82.5.1383.1383","volume":"82","author":"JF Seymour","year":"1993","unstructured":"9. Seymour JF, Gagel RF. Calcitriol: the major humoral mediator of hypercalcemia in Hodgkin&apos;s disease and non-Hodgkin&apos;s lymphomas. Blood 82: 1383-1394, 1993.","journal-title":"Blood","ISSN":"https:\/\/id.crossref.org\/issn\/0006-4971","issn-type":"print"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Seymour JF, Gagel RF, Hagemeister FB, Dimopoulos MA, Cabanillas F. Calcitriol production in hypercalcemic and normocalcemic patients with non-Hodgkin lymphoma. Ann Intern Med 121: 633-640, 1994.","DOI":"10.7326\/0003-4819-121-9-199411010-00001"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Mitobe M, Kawamoto K, Suzuki T, et al. Anaplastic large cell lymphoma, with 1,25 (OH) <sub>2<\/sub>D<sub>3<\/sub>-mediated hypercalcemia: a case report. J Clin Exp Hepatol 59: 22-28, 2019.","DOI":"10.3960\/jslrt.18033"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Hewison M, Kantorovich V, Liker HR, et al. Vitamin D-mediated hypercalcemia in lymphoma: evidence for hormone production by tumor-adjacent macrophages. J Bone Miner Res 18: 579-582, 2003.","DOI":"10.1359\/jbmr.2003.18.3.579"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Nakayama S, Matsuda M. 25-Hydroxyvitamin D<sub>3<\/sub>-1\u03b1-hydroxylase- and multiple cytokine-producing diffuse large B-cell lymphoma. Blood 131: 2271, 2018.","DOI":"10.1182\/blood-2018-02-832568"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Bikle DD, Patzek S, Wang Y. Physiologic and pathophysiologic roles of extra renal CYP27b1: case report and review. Bone Rep 8: 255-267, 2018.","DOI":"10.1016\/j.bonr.2018.02.004"},{"key":"15","doi-asserted-by":"publisher","unstructured":"15. Rasool SI, de Bergh C. Unique biosynthesis by kidney of a biologically active vitamin D metabolite. Nature 228: 764-766, 1970.","DOI":"10.1038\/228764a0"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. G L Barbour, J W Coburn, E Slatopolsky, A W Norman, R L Horst. Hypercalcemia in an anephric patient with sarcoidosis: evidence for extrarenal generation of 1,25-dihydroxyvitamin D. N Engl J Med 305: 440-443, 1981.","DOI":"10.1056\/NEJM198108203050807"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Adams JS, Sharma OP, Gacad MA, Singer FR. Metabolism of 25-hydroxyvitamin D<sub>3<\/sub> by cultured pulmonary alveolar macrophages in sarcoidosis. J Clin Invest 72: 1856-1860, 1983.","DOI":"10.1172\/JCI111147"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Adams JS, Hewison M. Extrarenal expression of the 25-hydroxyvitamin D-1-hydroxylase. Arch Biochem Biophy 523: 95-102, 2012.","DOI":"10.1016\/j.abb.2012.02.016"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Christakos S, Ajibade DV, Dhawan P, Fechner AJ, Mady LJ. Vitamin D: metabolism. Endocrinol Metab Clin North Am 39: 243-253, 2010.","DOI":"10.1016\/j.ecl.2010.02.002"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. Saponaro F, Saba A, Zucchi R. An update on vitamin D metabolism. Int J Mol Sci 21: 6573, 2020.","DOI":"10.3390\/ijms21186573"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. Tebben PJ, Singh RJ, Kumar R. Vitamin D-mediated hypercalcemia: mechanisms, diagnosis, and treatment. Endocr Rev 37: 521-547, 2016.","DOI":"10.1210\/er.2016-1070"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22. Sternlicht H, Glezerman IG. Hypercalcemia of malignancy and new treatment options. Ther Clin Risk Manag 11: 1779-1788, 2015.","DOI":"10.2147\/TCRM.S83681"}],"container-title":["Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/61\/16\/61_8933-21\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,20]],"date-time":"2022-08-20T03:18:52Z","timestamp":1660965532000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/61\/16\/61_8933-21\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8,15]]},"references-count":22,"journal-issue":{"issue":"16","published-print":{"date-parts":[[2022]]}},"URL":"https:\/\/doi.org\/10.2169\/internalmedicine.8933-21","relation":{},"ISSN":["0918-2918","1349-7235"],"issn-type":[{"value":"0918-2918","type":"print"},{"value":"1349-7235","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,8,15]]},"article-number":"8933-21"}}